Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Red-bellied black snake antivenom trial
ACTRN12611000588998Phase 4Recruiting
- Sponsor
- Geoff Isbister
- Start
- Apr 2014
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Red-bellied black snake envenoming comparing Tiger snake antivenom with Placebo (2 arms). Primary endpoint: Proportion of patients with myotoxicity. Started Apr 2014; status: recruiting.
02
Drugs
tiger snake antivenom
03
Conditions
Red-bellied black snake envenoming
Beyond the preview
Go deeper on ACTRN12611000588998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000588998.